Lebenthal Global Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.15M Buy
5,597
+1,320
+31% +$1.34M 0.75% 26
2025
Q4
$4.6M Sell
4,277
-2,739
-39% -$2.62M 0.71% 28
2025
Q3
$5.35M Buy
7,016
+4,039
+136% +$3.01M 0.94% 21
2025
Q2
$2.32M Buy
2,977
+563
+23% +$437K 0.43% 37
2025
Q1
$1.99M Sell
2,414
-615
-20% -$512K 0.37% 34
2024
Q4
$2.34M Buy
3,029
+852
+39% +$705K 0.43% 38
2024
Q3
$1.93M Buy
2,177
+243
+13% +$218K 0.39% 34
2024
Q2
$1.75M Buy
1,934
+243
+14% +$194K 0.38% 34
2024
Q1
$1.32M Sell
1,691
-276
-14% -$196K 0.29% 40
2023
Q4
$1.15M Buy
1,967
+1,349
+218% +$787K 0.27% 45
2023
Q3
$332K Sell
618
-1,279
-67% -$659K 0.1% 101
2023
Q2
$890K Sell
1,897
-199
-9% -$83.5K 0.26% 36
2023
Q1
$720K Sell
2,096
-222
-10% -$74.9K 0.22% 43
2022
Q4
$848K Buy
+2,318
New +$822K 0.28% 31
2022
Q2
Sell
-2,253
Closed -$645K 146
2022
Q1
$645K Buy
2,253
+219
+11% +$56.4K 0.27% 61
2021
Q4
$561K Buy
+2,034
New +$516K 0.23% 65
2021
Q1
Sell
-200
Closed -$33K 360
2020
Q4
$33K Buy
+200
New +$29.9K 0.02% 317

Other funds holding LLY

Lebenthal Global Advisors's LLY Position: Q1 2026 in Review

Lebenthal Global Advisors increased its Eli Lilly (LLY) stake by 31% in Q1 2026, buying an estimated $1.34M and bringing the position to 5,597 shares worth $5.15M. The position accounts for 0.75% of the portfolio, ranked #26.

Lebenthal Global Advisors first reported a position in LLY in Q4 2020 and has held it in 17 quarters since. The position peaked at $5.35M in Q3 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Lebenthal Global Advisors held 5,597 shares of Eli Lilly worth $5.15M as of Q1 2026.
  • Lebenthal Global Advisors bought 1,320 Eli Lilly shares in Q1 2026, an estimated $1.34M.
  • Eli Lilly made up 0.75% of Lebenthal Global Advisors's portfolio in Q1 2026, its #26 holding.
  • Lebenthal Global Advisors first reported a position in Eli Lilly in Q4 2020 and has held it in 17 quarters since.
  • Lebenthal Global Advisors's Eli Lilly position peaked at $5.35M in Q3 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Lebenthal Global Advisors's 13F filing for Q1 2026, filed 14 May 2026.